Log In
Saturday 24th August 2019


FT Health

Daily ‘polypill’ cuts risk of heart disease

Iranian trial shows clinical benefits of combining four cheap medicines

NMC Health: sick note

Shares have perked up on bid rumours, but keep taking the temperature 

NMC Health shares jump on report of Chinese interest in stake

UAE-based healthcare group is most shorted stock on FTSE 100

Gilead to challenge US patents on HIV drug Truvada

Move comes amid increasing scrutiny of drugmaker over pricing practices

Powell Jobs-backed start-up to offer ‘genetic counselling’

US government hires Color to provide human touch in massive health data research project

AstraZeneca faces setback in lung cancer drug trial

Combination including immunotherapy drug Imfinzi did not deliver hoped-for results

Nigeria to be last African nation declared polio-free

Wednesday marks three years since the last reported case on the continent

Bayer agrees $7.6bn sale of animal health business to Elanco

Deal will create second-biggest player in sector as German chemicals group looks to reorganise

Search for motor neurone disease cure gathers pace

Crick Institute links up with drug company Merck to tackle degenerative brain disorder

Juul raises $325m in fresh funding

Ecigarette maker plots overseas expansion despite scrutiny over teenage uptake

Novartis executive sold $1m shares ahead of probe

Company faces possible civil or criminal charges over manipulated Zolgensma data

How digital services are transforming UK mental healthcare

Start-ups such as Kooth cut down waiting times by connecting people to real-life therapists

Juvenescence raises another $100m to invest in longevity

UK biotech valued at $500m and aiming for IPO next year

Gilead did not seek US exclusivity on PrEP with Truvada

Drugmaker could be liable for billions in royalties to US government

Novartis ousted scientists before reporting data manipulation

US regulator investigates timing of revelation about studies behind world’s most expensive drug

Health ministry acts to ensure Brexit medicines supply

Fears of shortages in emergency drugs spurs £25m ‘express freight’ contract

NHS wins first payment over anti-competitive practice

Pharma company Aspen to pay £8m for fixing price of hormone imbalance drug

JPMorgan set to scoop record fee for Allergan sale

AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank

Ebola drugs trial raises prospect of cure

More than 90% of patients in Democratic Republic of Congo survived when treated early

Novartis benefits from faster China drug approvals

Swiss drugmaker expects its China sales to overtake Europe

US patients struggle to obtain Eli Lilly’s half-price insulin

Cheaper option was unveiled shortly before company was grilled by Congress about soaring prices

Australia and New Zealand to loosen abortion laws

Progressives set for victory as feared conservative backlash fails to materialise 

Record demand puts added strain on NHS

High volume of hospital attendance caused in part by summer heat

Bayer to buy rest of US biotech company in rare offensive move

Deal values BlueRock Therapeutics at $1bn

NHS looks to artificial intelligence to improve health

Johnson unveils plans for £250m national AI lab to build ‘cutting edge treatments’

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2019